<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(2)</volume><submitter>Lin G</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Currently, there is no reliable method for predicting the prognosis of patients with large cell lung cancer (LCLC). The aim of this study was to develop and validate a nomogram model for accurately predicting the prognosis of patients with LCLC.&lt;h4>Methods&lt;/h4>LCLC patients, diagnosed from 2007 to 2009, were identified from the Surveillance, Epidemiology and End Results (SEER) database and used as the training dataset. Significant clinicopathologic variables (P&lt;0.05) in a multivariate Cox regression were selected to build the nomogram. The performance of the nomogram model was evaluated by the concordance index (C-index), the area under the curve (AUC), and internal calibration. LCLC patients diagnosed from 2010 to 2016 in the SEER database were selected as a testing dat</pubmed_abstract><journal>Translational lung cancer research</journal><pagination>622-635</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7947411</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database.</pubmed_title><pmcid>PMC7947411</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Qi K</pubmed_authors><pubmed_authors>Lin G</pubmed_authors><pubmed_authors>Liu B</pubmed_authors></additional><is_claimable>false</is_claimable><name>A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database.</name><description>&lt;h4>Background&lt;/h4>Currently, there is no reliable method for predicting the prognosis of patients with large cell lung cancer (LCLC). The aim of this study was to develop and validate a nomogram model for accurately predicting the prognosis of patients with LCLC.&lt;h4>Methods&lt;/h4>LCLC patients, diagnosed from 2007 to 2009, were identified from the Surveillance, Epidemiology and End Results (SEER) database and used as the training dataset. Significant clinicopathologic variables (P&lt;0.05) in a multivariate Cox regression were selected to build the nomogram. The performance of the nomogram model was evaluated by the concordance index (C-index), the area under the curve (AUC), and internal calibration. LCLC patients diagnosed from 2010 to 2016 in the SEER database were selected as a testing dat</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Feb</publication><modification>2025-04-26T18:31:41.063Z</modification><creation>2025-02-19T01:41:08.476Z</creation></dates><accession>S-EPMC7947411</accession><cross_references><pubmed>33718009</pubmed><doi>10.21037/tlcr-19-517b</doi></cross_references></HashMap>